Families of Spinal Muscular Atrophy Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2003
NCT00374075
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

levocarnitine (carnitor) (2 trials)

valproic acid (depakene) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Muscular Atrophy (Phase 2)

Muscular Atrophy, Spinal (Phase 2)

Spinal Muscular Atrophies of Childhood (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2